Not independent
Tenure on this board
10.3 yrs
5 nominees · 1 ballot item.
Approval of the exercise in full of warrants to purchase 2,790,340 shares of Creative Medical Technology Holdings, Inc.'s common stock (the Inducement Warrants) at an exercise price of $2.86 per share, issued in October 2025, to be used to comply with Nasdaq Listing Rule 5635(d).
To approve the exercise in full of warrants to purchase 2,790,340 shares of the Company's Common Stock at a price of $2.86 per share (the “Inducement Warrants”) issued in the October 2025 warrant exercise transaction, as required by Nasdaq Listing Rule 5635(d).
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | 0.99% | 36,727 | $76K |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 0.55% | 20,350 | $42K |
| 3 | XTX Topco Ltd | 0.39% | 14,260 | $29K |
| 4 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.28% | 10,469 | $22K |
| 5 | VANGUARD FIDUCIARY TRUST CO | 0.15% | 5,518 | $11K |
| 6 | WELLS FARGO COMPANY/MN | 0.14% | 5,000 | $10K |
| 7 | Tower Research Capital LLC (TRC | 0.06% | 2,092 | $4K |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 0.04% | 1,563 | $3K |
| 9 | MORGAN STANLEY | 0.01% | 534 | $1K |
| 10 | FMR LLC | 0.01% | 250 | $515 |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.